Luca Morandi Luca Morandi, PhD, is a co-founder of Studium Genetics and serves as its Chief Research Officer. He has a 20-year track record in molecular oncology research with more than 100 published papers in peer-reviewed journals. He is the inventor of 6 granted patents and, currently, he is associate professor in clinical molecular biology at the Department of Biomedical and Neuromotor Sciences, University of Bologna. Davide Bartolomeo Gissi Achille Tarsitano Prof. Achille Tarsitano is a co-founder and a member of technical-scientific committee of Studium Genetics. He has more than 15-years track record in the management and treatment of patients…
Headquartered in Bologna, Italy, Studium Genetics is a spin-off company of Alma Mater Studiorum – University of Bologna that develops early diagnosis and prognosis predictive methods in the molecular oncology field, with particular regard to oral cancer. Studium Genetics is a company focused on precision medicine by a groundbreaking genomic and epigenomic testing, which generate reliable clinical data about the biology of each patient with cancer or neurological disorders. Backed by prestigious physicians and institutions, we aim at shifting the standard of care towards more innovative treatments. We focus our attention on epigenetic biomarkers, which have significantly contributed to improved diagnostic…
Our website address is: https://studiumgenetics.com. When visitors leave comments on the site we collect the data shown in the comments form, and also the visitor’s IP address and browser user agent string to help spam detection. An anonymized string created from your email address (also called a hash) may be provided to the Gravatar service to see if you are using it. The Gravatar service privacy policy is available here: https://automattic.com/privacy/. After approval of your comment, your profile picture is visible to the public in the context of your comment. If you upload images to the website, you should avoid…
